Maria Donzelli

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies”.

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01383-4

N/A

1.8DataRank · unranked

82 citations

Neeta Pandit‐Taskar, Brian H. Kushner, Pat Zanzonico, John L. Humm, Ursula Tomlinson +16 more

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Cell(2020)10.1016/j.cell.2020.07.009

N/A

1.1DataRank · unranked

1205 citations

Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez +95 more

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease

EJNMMI Research(2024)10.1186/s13550-024-01127-0

N/A

0.176DataRank · unranked

2 citations

Brian Serencsits, Bae P. Chu, Lawrence T. Dauer, Maria Donzelli, Ellen M. Basu +3 more

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease

Research Square(2024)10.21203/rs.3.rs-3969388/v1

N/A

0DataRank · unranked

0 citations

Brian Serencsits, Bae P. Chu, Lawrence T. Dauer, Maria Donzelli, Ellen M. Basu +3 more